BRIDGEBIO PHARMA INC

CUSIP: 10806XAD4 Class: Convertible Debt

ADVENT CAPITAL MANAGEMENT /DE/'s Holding History (CIK: 0001097278)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 20,513,000 Value ($000) $23,296 Avg Close — Range —
Q3 2025
Shares 21,691,000 Value ($000) $21,436 Avg Close — Range —
Q2 2025
Shares 15,340,000 Value ($000) $14,358 Avg Close — Range —
Q1 2025
Shares 16,798,000 Value ($000) $15,143 Avg Close — Range —
Q4 2024
Shares 2,688,000 Value ($000) $2,306 Avg Close — Range —
Q3 2024
Shares 18,944,000 Value ($000) $15,913 Avg Close — Range —
Q2 2024
Shares 23,193,000 Value ($000) $18,699 Avg Close — Range —
Q1 2024
Shares 40,049,000 Value ($000) $33,089 Avg Close — Range —
Q4 2023
Shares 35,715,000 Value ($000) $30,426 Avg Close — Range —
Q3 2023
Shares 29,488,000 Value ($000) $22,116 Avg Close — Range —
Q2 2023
Shares 1,800,000 Value ($000) $1,114 Avg Close — Range —
Q1 2023
Shares 1,800,000 Value ($000) $1,165 Avg Close — Range —